[Anti-TNF therapy and Crohn's disease].
Peyrin-Biroulet
L
L
Inserm, U724, service d'hépato-gastroentérologie, CHU Brabois, allée du Morvan, 54511 Vandoeuvre-lès-Nancy, France. peyrin-biroulet@netcourrier.com
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab